Bio-View Ltd (TLV:BIOV)
Israel · Delayed Price · Currency is ILS · Price in ILA 14.10
-0.10 (-0.71%)
Apr 3, 2026, 1:44 PM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 18.9 million as of April 2, 2026. Its market cap has decreased by -56.12% in one year.
Market Cap
18.90M
Enterprise Value
14.47M
Revenue
19.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.10
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 18.90M, a decrease of -68.40%. That is a compound annual growth rate of -5.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 18.90M | -15.57% |
| Dec 31, 2025 | 22.38M | -37.30% |
| Dec 31, 2024 | 35.69M | -21.62% |
| Dec 31, 2023 | 45.53M | -10.12% |
| Dec 29, 2022 | 50.66M | 13.09% |
| Dec 30, 2021 | 44.79M | -20.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 110.38B |
| Danel (Adir Yeoshua) | 2.64B |
| BrainsWay | 1.72B |
| Kamada | 1.50B |
| Evogene | 24.72M |
| Erika Carmel-Tech | 21.04M |
| Can-Fite BioPharma | 20.57M |
| XTL Biopharmaceuticals | 19.87M |